nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—Parkinson's disease—Diphenhydramine—atopic dermatitis	0.602	1	CpDpCtD
Pramipexole—SLC22A2—Diphenhydramine—atopic dermatitis	0.0577	0.535	CbGbCtD
Pramipexole—SLC22A1—Diphenhydramine—atopic dermatitis	0.0501	0.465	CbGbCtD
Pramipexole—DRD5—eyelid—atopic dermatitis	0.00998	0.627	CbGeAlD
Pramipexole—DRD3—head—atopic dermatitis	0.000673	0.0423	CbGeAlD
Pramipexole—DRD5—head—atopic dermatitis	0.000631	0.0396	CbGeAlD
Pramipexole—HTR2B—skin of body—atopic dermatitis	0.000539	0.0339	CbGeAlD
Pramipexole—DRD1—head—atopic dermatitis	0.000482	0.0303	CbGeAlD
Pramipexole—HTR2A—neck—atopic dermatitis	0.000445	0.0279	CbGeAlD
Pramipexole—HTR1B—head—atopic dermatitis	0.00039	0.0245	CbGeAlD
Pramipexole—SLC22A1—head—atopic dermatitis	0.000382	0.024	CbGeAlD
Pramipexole—HTR1D—head—atopic dermatitis	0.000378	0.0238	CbGeAlD
Pramipexole—HTR2C—head—atopic dermatitis	0.000374	0.0235	CbGeAlD
Pramipexole—HTR2B—head—atopic dermatitis	0.000352	0.0221	CbGeAlD
Pramipexole—HTR1A—head—atopic dermatitis	0.000315	0.0198	CbGeAlD
Pramipexole—DRD2—head—atopic dermatitis	0.000285	0.0179	CbGeAlD
Pramipexole—ADRA2C—head—atopic dermatitis	0.000277	0.0174	CbGeAlD
Pramipexole—ADRA2A—head—atopic dermatitis	0.000221	0.0139	CbGeAlD
Pramipexole—HTR2A—head—atopic dermatitis	0.000188	0.0118	CbGeAlD
Pramipexole—Loss of consciousness—Methylprednisolone—atopic dermatitis	3.96e-05	0.00018	CcSEcCtD
Pramipexole—Rash—Tacrolimus—atopic dermatitis	3.95e-05	0.00018	CcSEcCtD
Pramipexole—Dermatitis—Tacrolimus—atopic dermatitis	3.95e-05	0.00018	CcSEcCtD
Pramipexole—Shock—Prednisolone—atopic dermatitis	3.94e-05	0.00018	CcSEcCtD
Pramipexole—Cough—Triamcinolone—atopic dermatitis	3.94e-05	0.000179	CcSEcCtD
Pramipexole—Headache—Tacrolimus—atopic dermatitis	3.93e-05	0.000179	CcSEcCtD
Pramipexole—Oedema—Hydrocortisone—atopic dermatitis	3.91e-05	0.000178	CcSEcCtD
Pramipexole—Convulsion—Triamcinolone—atopic dermatitis	3.91e-05	0.000178	CcSEcCtD
Pramipexole—Tachycardia—Prednisolone—atopic dermatitis	3.91e-05	0.000178	CcSEcCtD
Pramipexole—Convulsion—Methylprednisolone—atopic dermatitis	3.9e-05	0.000178	CcSEcCtD
Pramipexole—Hypertension—Triamcinolone—atopic dermatitis	3.9e-05	0.000178	CcSEcCtD
Pramipexole—Hypertension—Methylprednisolone—atopic dermatitis	3.89e-05	0.000177	CcSEcCtD
Pramipexole—Infection—Hydrocortisone—atopic dermatitis	3.89e-05	0.000177	CcSEcCtD
Pramipexole—Hyperhidrosis—Prednisolone—atopic dermatitis	3.87e-05	0.000176	CcSEcCtD
Pramipexole—Shock—Hydrocortisone—atopic dermatitis	3.85e-05	0.000175	CcSEcCtD
Pramipexole—Myalgia—Triamcinolone—atopic dermatitis	3.84e-05	0.000175	CcSEcCtD
Pramipexole—Nervous system disorder—Hydrocortisone—atopic dermatitis	3.84e-05	0.000175	CcSEcCtD
Pramipexole—Myalgia—Methylprednisolone—atopic dermatitis	3.83e-05	0.000175	CcSEcCtD
Pramipexole—Arthralgia—Methylprednisolone—atopic dermatitis	3.83e-05	0.000175	CcSEcCtD
Pramipexole—Eye disorder—Prednisone—atopic dermatitis	3.83e-05	0.000174	CcSEcCtD
Pramipexole—Anxiety—Methylprednisolone—atopic dermatitis	3.82e-05	0.000174	CcSEcCtD
Pramipexole—Tachycardia—Hydrocortisone—atopic dermatitis	3.82e-05	0.000174	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	3.81e-05	0.000173	CcSEcCtD
Pramipexole—Flushing—Prednisone—atopic dermatitis	3.8e-05	0.000173	CcSEcCtD
Pramipexole—Skin disorder—Hydrocortisone—atopic dermatitis	3.8e-05	0.000173	CcSEcCtD
Pramipexole—Ill-defined disorder—Dexamethasone—atopic dermatitis	3.8e-05	0.000173	CcSEcCtD
Pramipexole—Ill-defined disorder—Betamethasone—atopic dermatitis	3.8e-05	0.000173	CcSEcCtD
Pramipexole—Discomfort—Triamcinolone—atopic dermatitis	3.8e-05	0.000173	CcSEcCtD
Pramipexole—Discomfort—Methylprednisolone—atopic dermatitis	3.79e-05	0.000173	CcSEcCtD
Pramipexole—Hyperhidrosis—Hydrocortisone—atopic dermatitis	3.78e-05	0.000172	CcSEcCtD
Pramipexole—Dry mouth—Triamcinolone—atopic dermatitis	3.76e-05	0.000171	CcSEcCtD
Pramipexole—Anorexia—Hydrocortisone—atopic dermatitis	3.73e-05	0.00017	CcSEcCtD
Pramipexole—Nausea—Tacrolimus—atopic dermatitis	3.72e-05	0.00017	CcSEcCtD
Pramipexole—Angiopathy—Prednisone—atopic dermatitis	3.72e-05	0.000169	CcSEcCtD
Pramipexole—Confusional state—Methylprednisolone—atopic dermatitis	3.71e-05	0.000169	CcSEcCtD
Pramipexole—Immune system disorder—Prednisone—atopic dermatitis	3.7e-05	0.000169	CcSEcCtD
Pramipexole—Malaise—Dexamethasone—atopic dermatitis	3.69e-05	0.000168	CcSEcCtD
Pramipexole—Malaise—Betamethasone—atopic dermatitis	3.69e-05	0.000168	CcSEcCtD
Pramipexole—Oedema—Triamcinolone—atopic dermatitis	3.68e-05	0.000168	CcSEcCtD
Pramipexole—Vertigo—Betamethasone—atopic dermatitis	3.68e-05	0.000168	CcSEcCtD
Pramipexole—Vertigo—Dexamethasone—atopic dermatitis	3.68e-05	0.000168	CcSEcCtD
Pramipexole—Syncope—Betamethasone—atopic dermatitis	3.67e-05	0.000167	CcSEcCtD
Pramipexole—Syncope—Dexamethasone—atopic dermatitis	3.67e-05	0.000167	CcSEcCtD
Pramipexole—Infection—Triamcinolone—atopic dermatitis	3.66e-05	0.000167	CcSEcCtD
Pramipexole—Hypotension—Hydrocortisone—atopic dermatitis	3.66e-05	0.000167	CcSEcCtD
Pramipexole—Infection—Methylprednisolone—atopic dermatitis	3.65e-05	0.000166	CcSEcCtD
Pramipexole—Shock—Triamcinolone—atopic dermatitis	3.62e-05	0.000165	CcSEcCtD
Pramipexole—Insomnia—Prednisolone—atopic dermatitis	3.62e-05	0.000165	CcSEcCtD
Pramipexole—Alopecia—Prednisone—atopic dermatitis	3.62e-05	0.000165	CcSEcCtD
Pramipexole—Shock—Methylprednisolone—atopic dermatitis	3.62e-05	0.000165	CcSEcCtD
Pramipexole—Nervous system disorder—Methylprednisolone—atopic dermatitis	3.6e-05	0.000164	CcSEcCtD
Pramipexole—Loss of consciousness—Dexamethasone—atopic dermatitis	3.6e-05	0.000164	CcSEcCtD
Pramipexole—Loss of consciousness—Betamethasone—atopic dermatitis	3.6e-05	0.000164	CcSEcCtD
Pramipexole—Paraesthesia—Prednisolone—atopic dermatitis	3.6e-05	0.000164	CcSEcCtD
Pramipexole—Tachycardia—Triamcinolone—atopic dermatitis	3.59e-05	0.000164	CcSEcCtD
Pramipexole—Mental disorder—Prednisone—atopic dermatitis	3.59e-05	0.000164	CcSEcCtD
Pramipexole—Tachycardia—Methylprednisolone—atopic dermatitis	3.59e-05	0.000163	CcSEcCtD
Pramipexole—Skin disorder—Methylprednisolone—atopic dermatitis	3.57e-05	0.000163	CcSEcCtD
Pramipexole—Malnutrition—Prednisone—atopic dermatitis	3.57e-05	0.000162	CcSEcCtD
Pramipexole—Erythema—Prednisone—atopic dermatitis	3.57e-05	0.000162	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	3.56e-05	0.000162	CcSEcCtD
Pramipexole—Hyperhidrosis—Triamcinolone—atopic dermatitis	3.56e-05	0.000162	CcSEcCtD
Pramipexole—Hyperhidrosis—Methylprednisolone—atopic dermatitis	3.55e-05	0.000162	CcSEcCtD
Pramipexole—Convulsion—Dexamethasone—atopic dermatitis	3.55e-05	0.000162	CcSEcCtD
Pramipexole—Convulsion—Betamethasone—atopic dermatitis	3.55e-05	0.000162	CcSEcCtD
Pramipexole—Insomnia—Hydrocortisone—atopic dermatitis	3.54e-05	0.000161	CcSEcCtD
Pramipexole—Hypertension—Betamethasone—atopic dermatitis	3.54e-05	0.000161	CcSEcCtD
Pramipexole—Hypertension—Dexamethasone—atopic dermatitis	3.54e-05	0.000161	CcSEcCtD
Pramipexole—Paraesthesia—Hydrocortisone—atopic dermatitis	3.51e-05	0.00016	CcSEcCtD
Pramipexole—Myalgia—Betamethasone—atopic dermatitis	3.49e-05	0.000159	CcSEcCtD
Pramipexole—Myalgia—Dexamethasone—atopic dermatitis	3.49e-05	0.000159	CcSEcCtD
Pramipexole—Anxiety—Dexamethasone—atopic dermatitis	3.47e-05	0.000158	CcSEcCtD
Pramipexole—Anxiety—Betamethasone—atopic dermatitis	3.47e-05	0.000158	CcSEcCtD
Pramipexole—Discomfort—Dexamethasone—atopic dermatitis	3.44e-05	0.000157	CcSEcCtD
Pramipexole—Discomfort—Betamethasone—atopic dermatitis	3.44e-05	0.000157	CcSEcCtD
Pramipexole—Dyspepsia—Hydrocortisone—atopic dermatitis	3.44e-05	0.000157	CcSEcCtD
Pramipexole—Hypotension—Methylprednisolone—atopic dermatitis	3.43e-05	0.000156	CcSEcCtD
Pramipexole—Pain—Prednisolone—atopic dermatitis	3.43e-05	0.000156	CcSEcCtD
Pramipexole—Decreased appetite—Hydrocortisone—atopic dermatitis	3.4e-05	0.000155	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	3.38e-05	0.000154	CcSEcCtD
Pramipexole—Fatigue—Hydrocortisone—atopic dermatitis	3.37e-05	0.000154	CcSEcCtD
Pramipexole—Vision blurred—Prednisone—atopic dermatitis	3.36e-05	0.000153	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	3.36e-05	0.000153	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	3.35e-05	0.000153	CcSEcCtD
Pramipexole—Pain—Hydrocortisone—atopic dermatitis	3.35e-05	0.000152	CcSEcCtD
Pramipexole—Oedema—Dexamethasone—atopic dermatitis	3.34e-05	0.000152	CcSEcCtD
Pramipexole—Oedema—Betamethasone—atopic dermatitis	3.34e-05	0.000152	CcSEcCtD
Pramipexole—Insomnia—Triamcinolone—atopic dermatitis	3.33e-05	0.000152	CcSEcCtD
Pramipexole—Insomnia—Methylprednisolone—atopic dermatitis	3.32e-05	0.000151	CcSEcCtD
Pramipexole—Infection—Dexamethasone—atopic dermatitis	3.32e-05	0.000151	CcSEcCtD
Pramipexole—Infection—Betamethasone—atopic dermatitis	3.32e-05	0.000151	CcSEcCtD
Pramipexole—Ill-defined disorder—Prednisone—atopic dermatitis	3.31e-05	0.000151	CcSEcCtD
Pramipexole—Paraesthesia—Triamcinolone—atopic dermatitis	3.31e-05	0.000151	CcSEcCtD
Pramipexole—Feeling abnormal—Prednisolone—atopic dermatitis	3.3e-05	0.00015	CcSEcCtD
Pramipexole—Paraesthesia—Methylprednisolone—atopic dermatitis	3.3e-05	0.00015	CcSEcCtD
Pramipexole—Anaemia—Prednisone—atopic dermatitis	3.3e-05	0.00015	CcSEcCtD
Pramipexole—Shock—Betamethasone—atopic dermatitis	3.29e-05	0.00015	CcSEcCtD
Pramipexole—Shock—Dexamethasone—atopic dermatitis	3.29e-05	0.00015	CcSEcCtD
Pramipexole—Dyspnoea—Triamcinolone—atopic dermatitis	3.28e-05	0.00015	CcSEcCtD
Pramipexole—Nervous system disorder—Dexamethasone—atopic dermatitis	3.28e-05	0.000149	CcSEcCtD
Pramipexole—Nervous system disorder—Betamethasone—atopic dermatitis	3.28e-05	0.000149	CcSEcCtD
Pramipexole—Agitation—Prednisone—atopic dermatitis	3.28e-05	0.000149	CcSEcCtD
Pramipexole—Thrombocytopenia—Dexamethasone—atopic dermatitis	3.27e-05	0.000149	CcSEcCtD
Pramipexole—Thrombocytopenia—Betamethasone—atopic dermatitis	3.27e-05	0.000149	CcSEcCtD
Pramipexole—Tachycardia—Dexamethasone—atopic dermatitis	3.26e-05	0.000149	CcSEcCtD
Pramipexole—Tachycardia—Betamethasone—atopic dermatitis	3.26e-05	0.000149	CcSEcCtD
Pramipexole—Dyspepsia—Triamcinolone—atopic dermatitis	3.24e-05	0.000148	CcSEcCtD
Pramipexole—Dyspepsia—Methylprednisolone—atopic dermatitis	3.24e-05	0.000147	CcSEcCtD
Pramipexole—Hyperhidrosis—Dexamethasone—atopic dermatitis	3.23e-05	0.000147	CcSEcCtD
Pramipexole—Hyperhidrosis—Betamethasone—atopic dermatitis	3.23e-05	0.000147	CcSEcCtD
Pramipexole—Feeling abnormal—Hydrocortisone—atopic dermatitis	3.22e-05	0.000147	CcSEcCtD
Pramipexole—Malaise—Prednisone—atopic dermatitis	3.22e-05	0.000147	CcSEcCtD
Pramipexole—Vertigo—Prednisone—atopic dermatitis	3.2e-05	0.000146	CcSEcCtD
Pramipexole—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	3.2e-05	0.000146	CcSEcCtD
Pramipexole—Syncope—Prednisone—atopic dermatitis	3.2e-05	0.000146	CcSEcCtD
Pramipexole—Anorexia—Betamethasone—atopic dermatitis	3.19e-05	0.000145	CcSEcCtD
Pramipexole—Anorexia—Dexamethasone—atopic dermatitis	3.19e-05	0.000145	CcSEcCtD
Pramipexole—Urticaria—Prednisolone—atopic dermatitis	3.18e-05	0.000145	CcSEcCtD
Pramipexole—Fatigue—Triamcinolone—atopic dermatitis	3.18e-05	0.000145	CcSEcCtD
Pramipexole—Fatigue—Methylprednisolone—atopic dermatitis	3.17e-05	0.000144	CcSEcCtD
Pramipexole—Pain—Triamcinolone—atopic dermatitis	3.15e-05	0.000143	CcSEcCtD
Pramipexole—Loss of consciousness—Prednisone—atopic dermatitis	3.13e-05	0.000143	CcSEcCtD
Pramipexole—Hypotension—Betamethasone—atopic dermatitis	3.12e-05	0.000142	CcSEcCtD
Pramipexole—Hypotension—Dexamethasone—atopic dermatitis	3.12e-05	0.000142	CcSEcCtD
Pramipexole—Urticaria—Hydrocortisone—atopic dermatitis	3.11e-05	0.000142	CcSEcCtD
Pramipexole—Abdominal pain—Hydrocortisone—atopic dermatitis	3.09e-05	0.000141	CcSEcCtD
Pramipexole—Body temperature increased—Hydrocortisone—atopic dermatitis	3.09e-05	0.000141	CcSEcCtD
Pramipexole—Convulsion—Prednisone—atopic dermatitis	3.09e-05	0.000141	CcSEcCtD
Pramipexole—Hypertension—Prednisone—atopic dermatitis	3.08e-05	0.00014	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	3.04e-05	0.000139	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	3.04e-05	0.000139	CcSEcCtD
Pramipexole—Myalgia—Prednisone—atopic dermatitis	3.04e-05	0.000138	CcSEcCtD
Pramipexole—Arthralgia—Prednisone—atopic dermatitis	3.04e-05	0.000138	CcSEcCtD
Pramipexole—Feeling abnormal—Triamcinolone—atopic dermatitis	3.04e-05	0.000138	CcSEcCtD
Pramipexole—Feeling abnormal—Methylprednisolone—atopic dermatitis	3.03e-05	0.000138	CcSEcCtD
Pramipexole—Anxiety—Prednisone—atopic dermatitis	3.03e-05	0.000138	CcSEcCtD
Pramipexole—Insomnia—Dexamethasone—atopic dermatitis	3.02e-05	0.000138	CcSEcCtD
Pramipexole—Insomnia—Betamethasone—atopic dermatitis	3.02e-05	0.000138	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	3.02e-05	0.000137	CcSEcCtD
Pramipexole—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	3.01e-05	0.000137	CcSEcCtD
Pramipexole—Paraesthesia—Dexamethasone—atopic dermatitis	3e-05	0.000137	CcSEcCtD
Pramipexole—Paraesthesia—Betamethasone—atopic dermatitis	3e-05	0.000137	CcSEcCtD
Pramipexole—Discomfort—Prednisone—atopic dermatitis	3e-05	0.000137	CcSEcCtD
Pramipexole—Hypersensitivity—Prednisolone—atopic dermatitis	2.95e-05	0.000134	CcSEcCtD
Pramipexole—Dyspepsia—Betamethasone—atopic dermatitis	2.94e-05	0.000134	CcSEcCtD
Pramipexole—Dyspepsia—Dexamethasone—atopic dermatitis	2.94e-05	0.000134	CcSEcCtD
Pramipexole—Urticaria—Triamcinolone—atopic dermatitis	2.93e-05	0.000133	CcSEcCtD
Pramipexole—Urticaria—Methylprednisolone—atopic dermatitis	2.92e-05	0.000133	CcSEcCtD
Pramipexole—Body temperature increased—Triamcinolone—atopic dermatitis	2.91e-05	0.000133	CcSEcCtD
Pramipexole—Oedema—Prednisone—atopic dermatitis	2.91e-05	0.000133	CcSEcCtD
Pramipexole—Abdominal pain—Methylprednisolone—atopic dermatitis	2.91e-05	0.000132	CcSEcCtD
Pramipexole—Decreased appetite—Dexamethasone—atopic dermatitis	2.91e-05	0.000132	CcSEcCtD
Pramipexole—Decreased appetite—Betamethasone—atopic dermatitis	2.91e-05	0.000132	CcSEcCtD
Pramipexole—Infection—Prednisone—atopic dermatitis	2.89e-05	0.000132	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Betamethasone—atopic dermatitis	2.89e-05	0.000131	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	2.89e-05	0.000131	CcSEcCtD
Pramipexole—Hypersensitivity—Hydrocortisone—atopic dermatitis	2.88e-05	0.000131	CcSEcCtD
Pramipexole—Fatigue—Betamethasone—atopic dermatitis	2.88e-05	0.000131	CcSEcCtD
Pramipexole—Fatigue—Dexamethasone—atopic dermatitis	2.88e-05	0.000131	CcSEcCtD
Pramipexole—Shock—Prednisone—atopic dermatitis	2.86e-05	0.00013	CcSEcCtD
Pramipexole—Pain—Betamethasone—atopic dermatitis	2.86e-05	0.00013	CcSEcCtD
Pramipexole—Pain—Dexamethasone—atopic dermatitis	2.86e-05	0.00013	CcSEcCtD
Pramipexole—Nervous system disorder—Prednisone—atopic dermatitis	2.85e-05	0.00013	CcSEcCtD
Pramipexole—Tachycardia—Prednisone—atopic dermatitis	2.84e-05	0.000129	CcSEcCtD
Pramipexole—Skin disorder—Prednisone—atopic dermatitis	2.83e-05	0.000129	CcSEcCtD
Pramipexole—Hyperhidrosis—Prednisone—atopic dermatitis	2.81e-05	0.000128	CcSEcCtD
Pramipexole—Asthenia—Hydrocortisone—atopic dermatitis	2.81e-05	0.000128	CcSEcCtD
Pramipexole—Anorexia—Prednisone—atopic dermatitis	2.77e-05	0.000126	CcSEcCtD
Pramipexole—Pruritus—Hydrocortisone—atopic dermatitis	2.77e-05	0.000126	CcSEcCtD
Pramipexole—Feeling abnormal—Dexamethasone—atopic dermatitis	2.75e-05	0.000125	CcSEcCtD
Pramipexole—Feeling abnormal—Betamethasone—atopic dermatitis	2.75e-05	0.000125	CcSEcCtD
Pramipexole—Gastrointestinal pain—Dexamethasone—atopic dermatitis	2.73e-05	0.000124	CcSEcCtD
Pramipexole—Gastrointestinal pain—Betamethasone—atopic dermatitis	2.73e-05	0.000124	CcSEcCtD
Pramipexole—Hypersensitivity—Triamcinolone—atopic dermatitis	2.71e-05	0.000124	CcSEcCtD
Pramipexole—Hypersensitivity—Methylprednisolone—atopic dermatitis	2.71e-05	0.000123	CcSEcCtD
Pramipexole—Diarrhoea—Hydrocortisone—atopic dermatitis	2.68e-05	0.000122	CcSEcCtD
Pramipexole—Urticaria—Dexamethasone—atopic dermatitis	2.66e-05	0.000121	CcSEcCtD
Pramipexole—Urticaria—Betamethasone—atopic dermatitis	2.66e-05	0.000121	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Prednisone—atopic dermatitis	2.65e-05	0.000121	CcSEcCtD
Pramipexole—Dizziness—Prednisolone—atopic dermatitis	2.65e-05	0.000121	CcSEcCtD
Pramipexole—Asthenia—Triamcinolone—atopic dermatitis	2.64e-05	0.00012	CcSEcCtD
Pramipexole—Body temperature increased—Dexamethasone—atopic dermatitis	2.64e-05	0.00012	CcSEcCtD
Pramipexole—Abdominal pain—Dexamethasone—atopic dermatitis	2.64e-05	0.00012	CcSEcCtD
Pramipexole—Body temperature increased—Betamethasone—atopic dermatitis	2.64e-05	0.00012	CcSEcCtD
Pramipexole—Abdominal pain—Betamethasone—atopic dermatitis	2.64e-05	0.00012	CcSEcCtD
Pramipexole—Asthenia—Methylprednisolone—atopic dermatitis	2.64e-05	0.00012	CcSEcCtD
Pramipexole—Insomnia—Prednisone—atopic dermatitis	2.63e-05	0.00012	CcSEcCtD
Pramipexole—Paraesthesia—Prednisone—atopic dermatitis	2.61e-05	0.000119	CcSEcCtD
Pramipexole—Pruritus—Triamcinolone—atopic dermatitis	2.61e-05	0.000119	CcSEcCtD
Pramipexole—Pruritus—Methylprednisolone—atopic dermatitis	2.6e-05	0.000118	CcSEcCtD
Pramipexole—Dizziness—Hydrocortisone—atopic dermatitis	2.59e-05	0.000118	CcSEcCtD
Pramipexole—Dyspepsia—Prednisone—atopic dermatitis	2.56e-05	0.000117	CcSEcCtD
Pramipexole—Decreased appetite—Prednisone—atopic dermatitis	2.53e-05	0.000115	CcSEcCtD
Pramipexole—Rash—Prednisolone—atopic dermatitis	2.53e-05	0.000115	CcSEcCtD
Pramipexole—Dermatitis—Prednisolone—atopic dermatitis	2.52e-05	0.000115	CcSEcCtD
Pramipexole—Diarrhoea—Methylprednisolone—atopic dermatitis	2.51e-05	0.000115	CcSEcCtD
Pramipexole—Fatigue—Prednisone—atopic dermatitis	2.51e-05	0.000114	CcSEcCtD
Pramipexole—Headache—Prednisolone—atopic dermatitis	2.51e-05	0.000114	CcSEcCtD
Pramipexole—Constipation—Prednisone—atopic dermatitis	2.49e-05	0.000113	CcSEcCtD
Pramipexole—Vomiting—Hydrocortisone—atopic dermatitis	2.49e-05	0.000113	CcSEcCtD
Pramipexole—Rash—Hydrocortisone—atopic dermatitis	2.47e-05	0.000112	CcSEcCtD
Pramipexole—Dermatitis—Hydrocortisone—atopic dermatitis	2.46e-05	0.000112	CcSEcCtD
Pramipexole—Headache—Hydrocortisone—atopic dermatitis	2.45e-05	0.000112	CcSEcCtD
Pramipexole—Dizziness—Triamcinolone—atopic dermatitis	2.44e-05	0.000111	CcSEcCtD
Pramipexole—Dizziness—Methylprednisolone—atopic dermatitis	2.43e-05	0.000111	CcSEcCtD
Pramipexole—Feeling abnormal—Prednisone—atopic dermatitis	2.4e-05	0.000109	CcSEcCtD
Pramipexole—Asthenia—Betamethasone—atopic dermatitis	2.4e-05	0.000109	CcSEcCtD
Pramipexole—Asthenia—Dexamethasone—atopic dermatitis	2.4e-05	0.000109	CcSEcCtD
Pramipexole—Gastrointestinal pain—Prednisone—atopic dermatitis	2.38e-05	0.000108	CcSEcCtD
Pramipexole—Nausea—Prednisolone—atopic dermatitis	2.38e-05	0.000108	CcSEcCtD
Pramipexole—Pruritus—Betamethasone—atopic dermatitis	2.36e-05	0.000108	CcSEcCtD
Pramipexole—Pruritus—Dexamethasone—atopic dermatitis	2.36e-05	0.000108	CcSEcCtD
Pramipexole—Vomiting—Triamcinolone—atopic dermatitis	2.34e-05	0.000107	CcSEcCtD
Pramipexole—Vomiting—Methylprednisolone—atopic dermatitis	2.34e-05	0.000106	CcSEcCtD
Pramipexole—Nausea—Hydrocortisone—atopic dermatitis	2.32e-05	0.000106	CcSEcCtD
Pramipexole—Rash—Triamcinolone—atopic dermatitis	2.32e-05	0.000106	CcSEcCtD
Pramipexole—Dermatitis—Triamcinolone—atopic dermatitis	2.32e-05	0.000106	CcSEcCtD
Pramipexole—Rash—Methylprednisolone—atopic dermatitis	2.32e-05	0.000106	CcSEcCtD
Pramipexole—Dermatitis—Methylprednisolone—atopic dermatitis	2.32e-05	0.000105	CcSEcCtD
Pramipexole—Urticaria—Prednisone—atopic dermatitis	2.31e-05	0.000105	CcSEcCtD
Pramipexole—Headache—Triamcinolone—atopic dermatitis	2.31e-05	0.000105	CcSEcCtD
Pramipexole—Headache—Methylprednisolone—atopic dermatitis	2.3e-05	0.000105	CcSEcCtD
Pramipexole—Body temperature increased—Prednisone—atopic dermatitis	2.3e-05	0.000105	CcSEcCtD
Pramipexole—Abdominal pain—Prednisone—atopic dermatitis	2.3e-05	0.000105	CcSEcCtD
Pramipexole—Diarrhoea—Dexamethasone—atopic dermatitis	2.29e-05	0.000104	CcSEcCtD
Pramipexole—Diarrhoea—Betamethasone—atopic dermatitis	2.29e-05	0.000104	CcSEcCtD
Pramipexole—Dizziness—Dexamethasone—atopic dermatitis	2.21e-05	0.000101	CcSEcCtD
Pramipexole—Dizziness—Betamethasone—atopic dermatitis	2.21e-05	0.000101	CcSEcCtD
Pramipexole—Nausea—Triamcinolone—atopic dermatitis	2.19e-05	9.97e-05	CcSEcCtD
Pramipexole—Nausea—Methylprednisolone—atopic dermatitis	2.18e-05	9.94e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Prednisone—atopic dermatitis	2.14e-05	9.77e-05	CcSEcCtD
Pramipexole—Vomiting—Betamethasone—atopic dermatitis	2.13e-05	9.68e-05	CcSEcCtD
Pramipexole—Vomiting—Dexamethasone—atopic dermatitis	2.13e-05	9.68e-05	CcSEcCtD
Pramipexole—Rash—Dexamethasone—atopic dermatitis	2.11e-05	9.6e-05	CcSEcCtD
Pramipexole—Rash—Betamethasone—atopic dermatitis	2.11e-05	9.6e-05	CcSEcCtD
Pramipexole—Dermatitis—Dexamethasone—atopic dermatitis	2.11e-05	9.59e-05	CcSEcCtD
Pramipexole—Dermatitis—Betamethasone—atopic dermatitis	2.11e-05	9.59e-05	CcSEcCtD
Pramipexole—Headache—Betamethasone—atopic dermatitis	2.09e-05	9.54e-05	CcSEcCtD
Pramipexole—Headache—Dexamethasone—atopic dermatitis	2.09e-05	9.54e-05	CcSEcCtD
Pramipexole—Asthenia—Prednisone—atopic dermatitis	2.09e-05	9.51e-05	CcSEcCtD
Pramipexole—Pruritus—Prednisone—atopic dermatitis	2.06e-05	9.38e-05	CcSEcCtD
Pramipexole—Diarrhoea—Prednisone—atopic dermatitis	1.99e-05	9.07e-05	CcSEcCtD
Pramipexole—Nausea—Dexamethasone—atopic dermatitis	1.99e-05	9.04e-05	CcSEcCtD
Pramipexole—Nausea—Betamethasone—atopic dermatitis	1.99e-05	9.04e-05	CcSEcCtD
Pramipexole—Dizziness—Prednisone—atopic dermatitis	1.92e-05	8.77e-05	CcSEcCtD
Pramipexole—Vomiting—Prednisone—atopic dermatitis	1.85e-05	8.43e-05	CcSEcCtD
Pramipexole—Rash—Prednisone—atopic dermatitis	1.84e-05	8.36e-05	CcSEcCtD
Pramipexole—Dermatitis—Prednisone—atopic dermatitis	1.83e-05	8.35e-05	CcSEcCtD
Pramipexole—Headache—Prednisone—atopic dermatitis	1.82e-05	8.31e-05	CcSEcCtD
Pramipexole—Nausea—Prednisone—atopic dermatitis	1.73e-05	7.88e-05	CcSEcCtD
Pramipexole—ADRA2A—Signaling Pathways—CCL11—atopic dermatitis	1.56e-05	0.000286	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL5—atopic dermatitis	1.56e-05	0.000286	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—CCR5—atopic dermatitis	1.55e-05	0.000285	CbGpPWpGaD
Pramipexole—DRD2—GPCR ligand binding—CXCL8—atopic dermatitis	1.55e-05	0.000285	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CCR5—atopic dermatitis	1.55e-05	0.000285	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL5—atopic dermatitis	1.54e-05	0.000282	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CXCL10—atopic dermatitis	1.53e-05	0.000281	CbGpPWpGaD
Pramipexole—HTR2A—GPCR ligand binding—CXCL8—atopic dermatitis	1.53e-05	0.00028	CbGpPWpGaD
Pramipexole—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.52e-05	0.000279	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—CXCL10—atopic dermatitis	1.52e-05	0.000279	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—IL2—atopic dermatitis	1.52e-05	0.000279	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—CCR5—atopic dermatitis	1.5e-05	0.000275	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CXCL10—atopic dermatitis	1.5e-05	0.000275	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NPS—atopic dermatitis	1.49e-05	0.000274	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TAC1—atopic dermatitis	1.49e-05	0.000274	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—CCR5—atopic dermatitis	1.49e-05	0.000274	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CXCL10—atopic dermatitis	1.48e-05	0.000271	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—STAT6—atopic dermatitis	1.47e-05	0.000269	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CXCR3—atopic dermatitis	1.46e-05	0.000269	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—CCL5—atopic dermatitis	1.46e-05	0.000268	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—IL2—atopic dermatitis	1.46e-05	0.000268	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—CCR5—atopic dermatitis	1.45e-05	0.000267	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—CCR5—atopic dermatitis	1.45e-05	0.000266	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NPS—atopic dermatitis	1.44e-05	0.000265	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TAC1—atopic dermatitis	1.44e-05	0.000265	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—CCL5—atopic dermatitis	1.44e-05	0.000265	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—CCL5—atopic dermatitis	1.44e-05	0.000264	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NPS—atopic dermatitis	1.43e-05	0.000263	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TAC1—atopic dermatitis	1.43e-05	0.000263	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—CCR5—atopic dermatitis	1.43e-05	0.000262	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCR3—atopic dermatitis	1.42e-05	0.000261	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CXCR3—atopic dermatitis	1.41e-05	0.00026	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CXCL10—atopic dermatitis	1.41e-05	0.000259	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CXCR3—atopic dermatitis	1.41e-05	0.000258	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCR3—atopic dermatitis	1.4e-05	0.000257	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NPS—atopic dermatitis	1.39e-05	0.000256	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TAC1—atopic dermatitis	1.39e-05	0.000256	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—CXCL8—atopic dermatitis	1.39e-05	0.000255	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL5—atopic dermatitis	1.39e-05	0.000255	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CXCR3—atopic dermatitis	1.37e-05	0.000251	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL5—atopic dermatitis	1.34e-05	0.000246	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—CXCL8—atopic dermatitis	1.34e-05	0.000246	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL5—atopic dermatitis	1.33e-05	0.000245	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CXCL10—atopic dermatitis	1.33e-05	0.000244	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CCL5—atopic dermatitis	1.32e-05	0.000242	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	1.32e-05	0.000242	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—NFKBIA—atopic dermatitis	1.31e-05	0.000241	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CXCL10—atopic dermatitis	1.31e-05	0.000241	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.31e-05	0.000241	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	1.31e-05	0.00024	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	1.3e-05	0.000238	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL5—atopic dermatitis	1.3e-05	0.000238	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—CCR5—atopic dermatitis	1.3e-05	0.000238	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CCL5—atopic dermatitis	1.29e-05	0.000237	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—CXCL8—atopic dermatitis	1.29e-05	0.000237	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—IL2—atopic dermatitis	1.28e-05	0.000235	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	1.27e-05	0.000233	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CCL5—atopic dermatitis	1.27e-05	0.000233	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TAC1—atopic dermatitis	1.27e-05	0.000232	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NPS—atopic dermatitis	1.27e-05	0.000232	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—IL2—atopic dermatitis	1.25e-05	0.00023	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NPS—atopic dermatitis	1.25e-05	0.000229	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	1.25e-05	0.000229	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	1.24e-05	0.000228	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—IL2—atopic dermatitis	1.23e-05	0.000226	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.23e-05	0.000226	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—NGF—atopic dermatitis	1.22e-05	0.000224	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	1.22e-05	0.000224	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—CXCL8—atopic dermatitis	1.22e-05	0.000223	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CCL5—atopic dermatitis	1.21e-05	0.000223	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—NGF—atopic dermatitis	1.2e-05	0.00022	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	1.19e-05	0.000219	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CCR5—atopic dermatitis	1.19e-05	0.000218	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—IL2—atopic dermatitis	1.19e-05	0.000218	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CXCL10—atopic dermatitis	1.18e-05	0.000217	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	1.18e-05	0.000216	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—IL2—atopic dermatitis	1.18e-05	0.000216	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—NGF—atopic dermatitis	1.18e-05	0.000216	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL5—atopic dermatitis	1.18e-05	0.000216	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—CXCL8—atopic dermatitis	1.17e-05	0.000215	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	1.16e-05	0.000214	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	1.16e-05	0.000213	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.16e-05	0.000213	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL5—atopic dermatitis	1.16e-05	0.000213	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—CXCL8—atopic dermatitis	1.15e-05	0.00021	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CCR5—atopic dermatitis	1.14e-05	0.00021	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CCL5—atopic dermatitis	1.14e-05	0.00021	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	1.14e-05	0.00021	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	1.14e-05	0.000209	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	1.14e-05	0.000209	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	1.13e-05	0.000208	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	1.13e-05	0.000208	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CCL5—atopic dermatitis	1.13e-05	0.000207	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NGF—atopic dermatitis	1.12e-05	0.000206	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—IL2—atopic dermatitis	1.12e-05	0.000206	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—CXCL8—atopic dermatitis	1.12e-05	0.000205	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	1.11e-05	0.000204	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—IL2—atopic dermatitis	1.11e-05	0.000204	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CXCL10—atopic dermatitis	1.11e-05	0.000203	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—IL2—atopic dermatitis	1.1e-05	0.000201	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CCR5—atopic dermatitis	1.09e-05	0.000201	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—IL2—atopic dermatitis	1.07e-05	0.000196	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NGF—atopic dermatitis	1.06e-05	0.000195	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—CXCL8—atopic dermatitis	1.05e-05	0.000194	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	1.05e-05	0.000193	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NGF—atopic dermatitis	1.05e-05	0.000192	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—CXCL8—atopic dermatitis	1.04e-05	0.000191	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.03e-05	0.00019	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CCR5—atopic dermatitis	1.03e-05	0.000189	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CCL5—atopic dermatitis	1.02e-05	0.000187	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CCR5—atopic dermatitis	1.02e-05	0.000187	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PPARA—atopic dermatitis	1.01e-05	0.000186	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL2—atopic dermatitis	1.01e-05	0.000185	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	1.01e-05	0.000185	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	1e-05	0.000184	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	9.99e-06	0.000183	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL2—atopic dermatitis	9.94e-06	0.000183	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	9.93e-06	0.000182	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—IL2—atopic dermatitis	9.89e-06	0.000182	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	9.87e-06	0.000181	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	9.86e-06	0.000181	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	9.84e-06	0.000181	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PPARA—atopic dermatitis	9.83e-06	0.000181	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	9.78e-06	0.00018	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—NFKBIA—atopic dermatitis	9.7e-06	0.000178	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	9.66e-06	0.000177	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	9.54e-06	0.000175	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	9.52e-06	0.000175	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	9.49e-06	0.000174	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	9.44e-06	0.000173	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PPARA—atopic dermatitis	9.42e-06	0.000173	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	9.39e-06	0.000173	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CXCL8—atopic dermatitis	9.38e-06	0.000172	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	9.26e-06	0.00017	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	9.23e-06	0.00017	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	9.18e-06	0.000169	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NGF—atopic dermatitis	9.11e-06	0.000167	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	9.07e-06	0.000167	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NGF—atopic dermatitis	9.06e-06	0.000166	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	9.02e-06	0.000166	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	8.98e-06	0.000165	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	8.98e-06	0.000165	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL2—atopic dermatitis	8.96e-06	0.000165	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—IL6—atopic dermatitis	8.92e-06	0.000164	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	8.86e-06	0.000163	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	8.82e-06	0.000162	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	8.81e-06	0.000162	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	8.77e-06	0.000161	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	8.77e-06	0.000161	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	8.74e-06	0.00016	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	8.67e-06	0.000159	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCL5—atopic dermatitis	8.64e-06	0.000159	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	8.63e-06	0.000158	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	8.62e-06	0.000158	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	8.62e-06	0.000158	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	8.57e-06	0.000157	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	8.5e-06	0.000156	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	8.39e-06	0.000154	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	8.38e-06	0.000154	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—MAPK8—atopic dermatitis	8.25e-06	0.000151	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	8.24e-06	0.000151	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NGF—atopic dermatitis	8e-06	0.000147	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PPARA—atopic dermatitis	7.98e-06	0.000147	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	7.96e-06	0.000146	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NGF—atopic dermatitis	7.87e-06	0.000144	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	7.85e-06	0.000144	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	7.83e-06	0.000144	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	7.78e-06	0.000143	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCR5—atopic dermatitis	7.78e-06	0.000143	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	7.73e-06	0.000142	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	7.65e-06	0.000141	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL2—atopic dermatitis	7.61e-06	0.00014	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	7.51e-06	0.000138	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	7.5e-06	0.000138	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	7.49e-06	0.000137	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	7.47e-06	0.000137	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	7.27e-06	0.000133	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	7.18e-06	0.000132	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	7.16e-06	0.000131	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	7.13e-06	0.000131	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	7.03e-06	0.000129	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	6.96e-06	0.000128	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CXCL8—atopic dermatitis	6.92e-06	0.000127	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL2—atopic dermatitis	6.86e-06	0.000126	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	6.83e-06	0.000125	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	6.81e-06	0.000125	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL2—atopic dermatitis	6.72e-06	0.000123	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	6.69e-06	0.000123	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL2—atopic dermatitis	6.61e-06	0.000121	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	6.61e-06	0.000121	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	6.6e-06	0.000121	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—IL6—atopic dermatitis	6.58e-06	0.000121	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	6.49e-06	0.000119	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	6.32e-06	0.000116	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL2—atopic dermatitis	6.31e-06	0.000116	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	6.28e-06	0.000115	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	6.23e-06	0.000114	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	6.19e-06	0.000114	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	6.15e-06	0.000113	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MAPK8—atopic dermatitis	6.09e-06	0.000112	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL2—atopic dermatitis	5.95e-06	0.000109	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL6—atopic dermatitis	5.92e-06	0.000109	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	5.9e-06	0.000108	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL2—atopic dermatitis	5.87e-06	0.000108	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL6—atopic dermatitis	5.84e-06	0.000107	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	5.81e-06	0.000107	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	5.55e-06	0.000102	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	5.48e-06	0.000101	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	5.41e-06	9.93e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	5.36e-06	9.84e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	5.33e-06	9.79e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	5.3e-06	9.74e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	5.28e-06	9.69e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL6—atopic dermatitis	5.27e-06	9.67e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	5.18e-06	9.52e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL2—atopic dermatitis	5.12e-06	9.4e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	5.09e-06	9.35e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL2—atopic dermatitis	5.09e-06	9.35e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	5.07e-06	9.31e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	4.95e-06	9.1e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	4.93e-06	9.05e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	4.88e-06	8.96e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	4.71e-06	8.65e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	4.7e-06	8.64e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	4.69e-06	8.61e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	4.63e-06	8.5e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	4.56e-06	8.37e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL2—atopic dermatitis	4.5e-06	8.25e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL6—atopic dermatitis	4.47e-06	8.21e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL2—atopic dermatitis	4.42e-06	8.12e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	4.4e-06	8.08e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	4.21e-06	7.73e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	4.14e-06	7.6e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	4.07e-06	7.48e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL6—atopic dermatitis	4.03e-06	7.41e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	4.02e-06	7.39e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	4e-06	7.35e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL6—atopic dermatitis	3.95e-06	7.25e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL6—atopic dermatitis	3.89e-06	7.14e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL6—atopic dermatitis	3.71e-06	6.81e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	3.7e-06	6.8e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL6—atopic dermatitis	3.5e-06	6.43e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL6—atopic dermatitis	3.45e-06	6.34e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	3.12e-06	5.72e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL6—atopic dermatitis	3.01e-06	5.53e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL6—atopic dermatitis	2.99e-06	5.5e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	2.91e-06	5.35e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL6—atopic dermatitis	2.64e-06	4.85e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL6—atopic dermatitis	2.6e-06	4.77e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	2.37e-06	4.34e-05	CbGpPWpGaD
